-
M.
Desnos-Ollivier,
S.
Bretagne,
Dorothée
Raoux,
D.
Hoinard,
F.
Dromer,
E.
Dannaoui
(2008)
Mutations in the fks1 Gene in Candida albicans, C. tropicalis, and C. krusei Correlate with Elevated Caspofungin MICs Uncovered in AM3 Medium Using the Method of the European Committee on Antibiotic Susceptibility Testing
Antimicrobial Agents and Chemotherapy, 52
-
M.
Pfaller,
V.
Chaturvedi,
D.
Diekema,
M.
Ghannoum,
N.
Holliday,
S.
Killian,
C.
Knapp,
S.
Messer,
A.
Miskov,
R.
Ramani
(2008)
Clinical Evaluation of the Sensititre YeastOne Colorimetric Antifungal Panel for Antifungal Susceptibility Testing of the Echinocandins Anidulafungin, Caspofungin, and Micafungin
Journal of Clinical Microbiology, 46
-
J.
Kahn,
G.
García-Effrón,
M.
Hsu,
Steven
Park,
K.
Marr,
D.
Perlin
(2007)
Acquired Echinocandin Resistance in a Candida krusei Isolate Due to Modification of Glucan Synthase
Antimicrobial Agents and Chemotherapy, 51
-
E.
Cantón,
J.
Pemán,
A.
Valentín,
A.
Espinel-Ingroff,
M.
Gobernado
(2009)
In Vitro Activities of Echinocandins against Candida krusei Determined by Three Methods: MIC and Minimal Fungicidal Concentration Measurements and Time-Kill Studies
Antimicrobial Agents and Chemotherapy, 53
-
W.
Novick
(1989)
Development of in vitro susceptibility testing criteria and quality control parameters
Clinical Microbiology Newsletter, 11
-
M.
Baixench,
Naji
Aoun,
M.
Desnos-Ollivier,
D.
Garcia-Hermoso,
S.
Bretagne,
Sandrine
Ramires,
C.
Piketty,
E.
Dannaoui
(2007)
Acquired resistance to echinocandins in Candida albicans: case report and review.
The Journal of antimicrobial chemotherapy, 59 6
-
M.
Pfaller,
L.
Boyken,
R.
Hollis,
J.
Kroeger,
S.
Messer,
S.
Tendolkar,
R.
Jones,
J.
Turnidge,
D.
Diekema
(2009)
Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Echinocandins and Candida spp
Journal of Clinical Microbiology, 48
-
A.
Espinel-Ingroff,
E.
Cantón,
E.
Martín-Mazuelos,
J.
Pemán
(2009)
pharmacotherapy of Candida Infections with echinocandins
Clinical Medicine and Therapeutics, 2009
-
M.
Pfaller,
S.
Messer,
K.
Mills,
A.
Bolmström,
R.
Jones
(2001)
Evaluation of Etest Method for Determining Caspofungin (MK-0991) Susceptibilities of 726 Clinical Isolates of CandidaSpecies
Journal of Clinical Microbiology, 39
-
A.
Espinel-Ingroff
(2003)
Evaluation of Broth Microdilution Testing Parameters and Agar Diffusion Etest Procedure for Testing Susceptibilities of Aspergillus spp. to Caspofungin Acetate (MK-0991)
Journal of Clinical Microbiology, 41
-
J.
Rex,
B.
Alexander,
B.
Arthington-Skaggs,
Steven
Brown,
V.
Chaturvedi,
L.
Ostrosky-Zeichner,
M.
Pfaller,
D.
Sheehan,
T.
Walsh
(2008)
Reference method for broth dilution antifungal susceptibility testing of yeasts : Third informational supplement
-
P.
Pappas,
C.
Kauffman,
D.
Andes,
D.
Benjamin,
T.
Calandra,
J.
Edwards,
S.
Filler,
J.
Fisher,
B.
Kullberg,
L.
Ostrosky-Zeichner,
A.
Reboli,
J.
Rex,
T.
Walsh,
J.
Sobel
(2009)
Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 48 5
-
M.
Arendrup,
S.
Perkhofer,
S.
Howard,
G.
García-Effrón,
Aimanianda
Vishukumar,
D.
Perlin,
C.
Lass‐Flörl
(2008)
Establishing In Vitro-In Vivo Correlations for Aspergillus fumigatus: the Challenge of Azoles versus Echinocandins
Antimicrobial Agents and Chemotherapy, 52
-
G.
García-Effrón,
S.
Katiyar,
Steven
Park,
T.
Edlind,
D.
Perlin
(2008)
A Naturally Occurring Proline-to-Alanine Amino Acid Change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis Accounts for Reduced Echinocandin Susceptibility
Antimicrobial Agents and Chemotherapy, 52
-
G.
García-Effrón,
Steven
Park,
D.
Perlin
(2008)
Correlating Echinocandin MIC and Kinetic Inhibition of fks1 Mutant Glucan Synthases for Candida albicans: Implications for Interpretive Breakpoints
Antimicrobial Agents and Chemotherapy, 53
-
M.
Arendrup,
G.
García-Effrón,
W.
Buzina,
K.
Mortensen,
Nanna
Reiter,
Christian
Lundin,
H.
Jensen,
C.
Lass‐Flörl,
D.
Perlin,
B.
Bruun
(2008)
Breakthrough Aspergillus fumigatus and Candida albicans Double Infection during Caspofungin Treatment: Laboratory Characteristics and Implication for Susceptibility Testing
Antimicrobial Agents and Chemotherapy, 53
-
M.
Pfaller,
M.
Castanheira,
D.
Diekema,
S.
Messer,
Gary
Moet,
R.
Jones
(2010)
Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest Methods with the CLSI Broth Microdilution Method for Echinocandin Susceptibility Testing of Candida Species
Journal of Clinical Microbiology, 48
-
B.
Alexander,
T.
Byrne,
Kelly
Smith,
K.
Hanson,
K.
Anstrom,
J.
Perfect,
L.
Reller
(2007)
Comparative Evaluation of Etest and Sensititre YeastOne Panels against the Clinical and Laboratory Standards Institute M27-A2 Reference Broth Microdilution Method for Testing Candida Susceptibility to Seven Antifungal Agents
Journal of Clinical Microbiology, 45
-
E.
Cantón,
J.
Pemán,
M.
Sastre,
M.
Romero,
A.
Espinel-Ingroff
(2006)
Killing Kinetics of Caspofungin, Micafungin, and Amphotericin B against Candida guilliermondii
Antimicrobial Agents and Chemotherapy, 50
-
John
Turnidge,
Gunnar
Kahlmeter,
Göran
Kronvall
(2006)
Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 12 5
-
E.
Chryssanthou,
M.
Cuenca‐Estrella
(2002)
Comparison of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing Proposed Standard and the E-Test with the NCCLS Broth Microdilution Method for Voriconazole and Caspofungin Susceptibility Testing of Yeast Species
Journal of Clinical Microbiology, 40
-
M.
Pfaller,
L.
Boyken,
R.
Hollis,
J.
Kroeger,
S.
Messer,
S.
Tendolkar,
D.
Diekema
(2007)
In Vitro Susceptibility of Invasive Isolates of Candida spp. to Anidulafungin, Caspofungin, and Micafungin: Six Years of Global Surveillance
Journal of Clinical Microbiology, 46
-
Mahmoud
Ghannoum,
A.
Chen,
A.
Chen,
M.
Buhari,
J.
Chandra,
P.
Mukherjee,
D.
Baxa,
A.
Golembieski,
Jose
Vazquez,
J.
Vázquez
(2009)
Differential in vitro activity of anidulafungin, caspofungin and micafungin against Candida parapsilosis isolates recovered from a burn unit.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 15 3
-
A.
Reboli,
C.
Rotstein,
P.
Pappas,
S.
Chapman,
D.
Kett,
Deepali
Kumar,
R.
Betts,
M.
Wible,
B.
Goldstein,
J.
Schranz,
D.
Krause,
T.
Walsh
(2007)
Anidulafungin versus fluconazole for invasive candidiasis.
The New England journal of medicine, 356 24
-
M.
Jacobsen,
J.
Whyte,
F.
Odds
(2007)
Candida albicans and Candida dubliniensis Respond Differently to Echinocandin Antifungal Agents In Vitro
Antimicrobial Agents and Chemotherapy, 51
-
V.
Chaturvedi,
M.
Pfaller,
D.
Sheehan,
T.
Walsh
(2008)
Reference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard
-
M.
Krogh-Madsen,
M.
Arendrup,
L.
Heslet,
J.
Knudsen
(2006)
Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 42 7
-
D.
Krause,
J.
Reinhardt,
J.
Vázquez,
A.
Reboli,
B.
Goldstein,
M.
Wible,
T.
Henkel
(2004)
Phase 2, Randomized, Dose-Ranging Study Evaluating the Safety and Efficacy of Anidulafungin in Invasive Candidiasis and Candidemia
Antimicrobial Agents and Chemotherapy, 48
-
S.
Magill,
C.
Shields,
C.
Sears,
M.
Choti,
W.
Merz
(2006)
Triazole Cross-Resistance among Candida spp.: Case Report, Occurrence among Bloodstream Isolates, and Implications for Antifungal Therapy
Journal of Clinical Microbiology, 44
-
G.
García-Effrón,
D.
Kontoyiannis,
R.
Lewis,
D.
Perlin
(2008)
Caspofungin-Resistant Candida tropicalis Strains Causing Breakthrough Fungemia in Patients at High Risk for Hematologic Malignancies
Antimicrobial Agents and Chemotherapy, 52
-
A.
Dalhoff,
P.
Ambrose,
J.
Mouton
(2009)
A Long Journey from Minimum Inhibitory Concentration Testing to Clinically Predictive Breakpoints: Deterministic and Probabilistic Approaches in Deriving Breakpoints
Infection, 37
-
M.
Desnos-Ollivier,
F.
Dromer,
E.
Dannaoui
(2008)
Detection of Caspofungin Resistance in Candida spp. by Etest
Journal of Clinical Microbiology, 46
-
C.
Douglas,
J.
D'Ippolito,
G.
Shei,
M.
Meinz,
J.
Onishi,
J.
Marrinan,
W.
Li,
G.
Abruzzo,
A.
Flattery,
K.
Bartizal,
A.
Mitchell,
M.
Kurtz
(1997)
Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors
Antimicrobial Agents and Chemotherapy, 41
-
F.
Barchiesi,
E.
Spreghini,
S.
Tomassetti,
A.
Vittoria,
D.
Arzeni,
E.
Manso,
G.
Scalise
(2006)
Effects of Caspofungin against Candida guilliermondii and Candida parapsilosis
Antimicrobial Agents and Chemotherapy, 50
-
(2007)
Pharmacodynamics of anidulafungin against six Candida species
-
(2003)
Class II special controls guidance document: antimicrobial susceptibility test systems; guidance for industry. Food and Drug Administration
